Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-453-125"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120911.32.2-453-125"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"Addressing the shortage of tissue and cells available for medical purposes is a growing challenge for all EU Member States. This report focuses on three main objectives: increased harvesting of umbilical cord blood, further expansion of stem cell donation, and financial compensation for potential tissue donors.
Umbilical cord blood contains 10 times as many stem cells as bone marrow, but in many Member States it is wasted. I voted in favour of this report because it encourages the introduction of appropriate, transparent, and regularly audited financial compensation for potential donors. By attracting donors, this will ensure a steady supply of vital stem cells. The compensation will cover only the cost incurred in donation, protecting the health of the donor while upholding the ethical argument that the human body must not become a priced commodity.
I agree with my colleagues that this initiative will allow EU citizens greater access to life-saving and tissue-regenerating stem cells, while increasing the transparency and traceability of donations. This will ensure the safety of stem cell use and provide for a plentiful donated supply of quality tissue and cells."@en1
|
lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples